🔵 Public company Windtree announces $520 million in new financing to expand its BNB funding strategy DeThings, July 25 - According to Globenewswire, biotechnology company Windtree Therapeutics, Inc. (NASDAQ: WINT) announced that it has signed a common stock purchase agreement worth up to $500 million to establish an equity line of credit ("ELOC") and strengthen its BNB cryptocurrency funding strategy. The company also signed an additional stock purchase agreement worth $20 million with Build and Build Corp. 99% of the funds raised from ELOC and Build and Build Corp will be used to acquire BNB cryptocurrency.
Show original
3.72K
0
The content on this page is provided by third parties. Unless otherwise stated, OKX is not the author of the cited article(s) and does not claim any copyright in the materials. The content is provided for informational purposes only and does not represent the views of OKX. It is not intended to be an endorsement of any kind and should not be considered investment advice or a solicitation to buy or sell digital assets. To the extent generative AI is utilized to provide summaries or other information, such AI generated content may be inaccurate or inconsistent. Please read the linked article for more details and information. OKX is not responsible for content hosted on third party sites. Digital asset holdings, including stablecoins and NFTs, involve a high degree of risk and can fluctuate greatly. You should carefully consider whether trading or holding digital assets is suitable for you in light of your financial condition.